Low-molecular-mass Purine Nucleoside Phosphorylase: Characterization and Application in Enzymatic Synthesis of Nucleoside Antiviral Drugs

Xixian Xie,Jungang Xia,Kuifu He,Lining Lu,Qingyang Xu,Ning Chen
DOI: https://doi.org/10.1007/s10529-011-0535-6
2011-01-01
Biotechnology Letters
Abstract:Purine nucleoside phosphorylase (PNP) that catalyzes the reversible phosphorolysis of various purine nucleosides is widely distributed in prokaryotes and eukaryotes. Four pnp genes from Bacillus subtilis 168, Escherichia coli K-12 and Pseudoalteromonas sp. XM2107 were cloned by PCR and expressed in E. coli XL1-Blue. Recombinant PNPs (rPNPs) were purified by Ni(2+)-NTA chromatography. Compared with other rPNPs, PNP(816) was a low-molecular-mass homotrimer, which exhibited 11-, 4- and 1.5-fold higher values in k (cat)/K (m) using inosine as the substrate at 37°C. The PNP(816) or engineered strain XBlue (pQE-816) had a higher catalytic activity than other rPNPs or engineered strains during the enzymatic synthesis of ribavirin, which suggested that the low-molecular-mass homotrimer derived from microorganisms has higher catalytic activity for synthesis of nucleoside antiviral drugs.
What problem does this paper attempt to address?